About this trial
Difficult airway management remains the leading cause of anaesthesia-related morbidity and mortality. Obstructive sleep apnea syndrome (OSAS) is a warning sign of difficult airway management. Polysomnography is the gold standard for diagnosis of this syndrome, but the STOP-BANG questionnaire is the preferred screening test. In this study, we wanted to find an answer to the question How successful is the STOP-BANG questionnaire in screening for obstructive sleep apnea syndrome (OSAS) in predicting OSAS, difficult mask and difficult intubation in patients undergoing thoracic surgery?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient undergoing thoracic surgery
18-65 years old
ASA 1-3
Disqualifiers
Having a history of obstructive sleep apnea syndrome,
Having a history of previous head and neck surgery/radiotherapy,
Patients who did not agree to participate in the study
Trial population
Patients between the ages of 18-65, ASA 1-3, who will undergo thoracic surgery at the Ankara Atatürk Sanatorium Training and Research Hospital of the University of Health Sciences will be included in the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
STOP BANG
Other interventionThe STOP-Bang Questionnaire is intended to give physicians an easy-to-use tool to identify people who might have obstructive sleep apnea (OSA). The questionnaire consists of eight yes-or-no questions based on the major risk factors for OSA. A STOP-Bang score of 2 or less is considered low risk, and a score of 5 or more is high risk for having either moderate or severe OSA. For people who score 3 or 4, doctors may need to perform further assessment to determine how likely they are to have OSA.
Treatment groups
Trial outcomes
Primary outcomes
STOP-BANG questionnaire
A STOP-Bang score of 2 or less is considered low risk, and a score of 5 or more is high risk for having either moderate or severe obstructive sleep apnea (OSA). For people who score 3 or 4, doctors may need to perform further assessment to determine how likely they are to have OSA.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.